Be Biopharma logo

Be Biopharma

Engineered B cells as medicines

46 employees · est. 2020 · Cambridge, United States

VS
GDMC logo

GDMC

GDMC is a next generation design and manufacturing organization focused next-gen advanced genetic medicines.

61 employees · est. 2021 · Singapore, Singapore

Be Biopharma is the older company (2020 vs 2021); GDMC is the larger of the two.

Side-by-Side Comparison

Be Biopharma GDMC
Founded
2020 older 2021
Headquarters
Cambridge, United States Singapore, Singapore
Employees
46 61 larger
Industry
Biopharma, Biotechnology, Pharmaceutical Biopharma, Biotechnology, Manufacturing
Funding Stage
Series C Series A
Total Funding
$356.00M $21.00M
Funding Rounds
4 1
Services
Development of B Cell Medicines, Clinical Trial Management, Preclinical Research in Protein-Based Therapies karaoke room rental, themed entertainment experiences, personalized customer service
Target Customers
Patients with Hemophilia B, Patients with Hypophosphatasia, Healthcare Providers, Medical Researchers young adults, university students, music enthusiasts, private event organizers
Taxonomy
Engineered B Cell Medicines, Hemophilia B Treatment, Genetic Disease Therapies, Cancer Cell Therapy, Biotech Research, Cell Therapies, B Cell Engineering, Biopharmaceuticals, Innovative Therapeutics, Patient-Centric Approach, Cell Therapy Manufacturing, Medical Biotechnology Genetic Medicines, Gene Therapies, Nucleic Acid Therapies, Process Development, Bio Manufacturing, Therapeutic Modalities, Clinical Trials Support, Early-stage Partnerships, Innovation In Healthcare, Drug Development Acceleration, Facility Development, Patient-centric Innovations, Equal Opportunity Employer
Website
be.bio gdmc.bio
Be Biopharma logo

About Be Biopharma

Be Biopharma, founded in 2020, is a pioneering player in the Biopharma and Biotechnology sectors. The company's innovative approach is encapsulated in its slogan, "Engineered B cells as medicines," highlighting its commitment to developing novel treatments to significantly enhance patient outcomes....

GDMC logo

About GDMC

GDMC, short for Genetic Design and Manufacturing Corporation, represents an ambitious stride in the biopharmaceutical industry, founded in 2021. Positioned at the forefront of next-generation advanced genetic medicines, GDMC operates out of Singapore, focusing on partnerships with early-stage compan...

We will tell you when either one moves

BounceWatch watches Be Biopharma and GDMC for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Be Biopharma and GDMC — by email.

Frequently Asked Questions

Be Biopharma — Engineered B cells as medicines. GDMC — GDMC is a next generation design and manufacturing organization focused next-gen advanced genetic medicines.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Be Biopharma has raised $356.00M while GDMC has raised $21.00M.
Be Biopharma and GDMC operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Be Biopharma with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Be Biopharma on 9 Jun 2026, and GDMC on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy